246 related articles for article (PubMed ID: 9779717)
21. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Motzer RJ; Mazumdar M; Bajorin DF; Bosl GJ; Lyn P; Vlamis V
J Clin Oncol; 1997 Jul; 15(7):2546-52. PubMed ID: 9215823
[TBL] [Abstract][Full Text] [Related]
22. High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Kushner BH; Heller G; Cheung NK; Wollner N; Kramer K; Bajorin D; Polyak T; Meyers PA
J Clin Oncol; 1998 Sep; 16(9):3016-20. PubMed ID: 9738570
[TBL] [Abstract][Full Text] [Related]
23. Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer.
Yagita M; Ieki Y; Onishi R; Huang CL; Adachi M; Horiike S; Konaka Y; Taki T; Miyake M
Int J Oncol; 1998 Jul; 13(1):91-6. PubMed ID: 9625808
[TBL] [Abstract][Full Text] [Related]
24. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
Pui CH; Relling MV; Behm FG; Hancock ML; Boyett JM; Raimondi SC; Krance RA; Mahmoud HH; Ribeiro RC; Sandlund JT
Leukemia; 1995 Oct; 9(10):1680-4. PubMed ID: 7564509
[TBL] [Abstract][Full Text] [Related]
25. Secondary tumours following etoposide containing therapy for germ cell cancer.
Boshoff C; Begent RH; Oliver RT; Rustin GJ; Newlands ES; Andrews R; Skelton M; Holden L; Ong J
Ann Oncol; 1995 Jan; 6(1):35-40. PubMed ID: 7536027
[TBL] [Abstract][Full Text] [Related]
26. Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors.
Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
Anticancer Res; 2006; 26(6C):4965-8. PubMed ID: 17214371
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
[TBL] [Abstract][Full Text] [Related]
28. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL
J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056
[TBL] [Abstract][Full Text] [Related]
29. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Bhatia S; Krailo MD; Chen Z; Burden L; Askin FB; Dickman PS; Grier HE; Link MP; Meyers PA; Perlman EJ; Rausen AR; Robison LL; Vietti TJ; Miser JS
Blood; 2007 Jan; 109(1):46-51. PubMed ID: 16985182
[TBL] [Abstract][Full Text] [Related]
30. Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Imashuku S; Teramura T; Kuriyama K; Kitazawa J; Ito E; Morimoto A; Hibi S
Int J Hematol; 2002 Feb; 75(2):174-7. PubMed ID: 11939264
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
Bajorin DF; Sarosdy MF; Pfister DG; Mazumdar M; Motzer RJ; Scher HI; Geller NL; Fair WR; Herr H; Sogani P
J Clin Oncol; 1993 Apr; 11(4):598-606. PubMed ID: 8386751
[TBL] [Abstract][Full Text] [Related]
32. High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
Adra N; Abonour R; Althouse SK; Albany C; Hanna NH; Einhorn LH
J Clin Oncol; 2017 Apr; 35(10):1096-1102. PubMed ID: 27870561
[TBL] [Abstract][Full Text] [Related]
33. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Fléchon A; Biron P; Philip I; Blay JY; Droz JP
Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
[TBL] [Abstract][Full Text] [Related]
34. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
35. Therapy-related malignancies following treatment of germ cell cancer.
Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
Int J Cancer; 1999 Dec; 83(6):860-3. PubMed ID: 10597212
[TBL] [Abstract][Full Text] [Related]
36. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.
Le Deley MC; Leblanc T; Shamsaldin A; Raquin MA; Lacour B; Sommelet D; Chompret A; Cayuela JM; Bayle C; Bernheim A; de Vathaire F; Vassal G; Hill C;
J Clin Oncol; 2003 Mar; 21(6):1074-81. PubMed ID: 12637473
[TBL] [Abstract][Full Text] [Related]
37. [Small cell lung cancer with acute monocytic leukemia after combined chemotherapy including etoposide].
Tamada T; Kimura K; Tabata M; Ishimori S; Tsuburaya T; Hayashi M
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):577-82. PubMed ID: 9234639
[TBL] [Abstract][Full Text] [Related]
38. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.
Krishnan A; Bhatia S; Slovak ML; Arber DA; Niland JC; Nademanee A; Fung H; Bhatia R; Kashyap A; Molina A; O'Donnell MR; Parker PA; Sniecinski I; Snyder DS; Spielberger R; Stein A; Forman SJ
Blood; 2000 Mar; 95(5):1588-93. PubMed ID: 10688812
[TBL] [Abstract][Full Text] [Related]
39. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Orlandi E; Lazzarino M; Bernasconi P; Astori C; Bernasconi C
Haematologica; 1998 Aug; 83(8):758-9. PubMed ID: 9793267
[TBL] [Abstract][Full Text] [Related]
40. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
Kröger N; Zander AR; Martinelli G; Ferrante P; Moraleda JM; Da Prada GA; Demirer T; Socie G; Rosti G;
Ann Oncol; 2003 Apr; 14(4):554-8. PubMed ID: 12649100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
